Physician profile
Michael Norman
NPI 1912978123
$980.77
in general payments reported to CMS, 2019-2025
18 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.89 · 2020: $26.07 · 2021: $118 · 2022: $122 · 2023: $221 · 2024: $243 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $396.72 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $106.86 | 2021-2025 | Mounjaro |
| Merck Sharp & Dohme LLC | $90.87 | 2022-2025 | Verquvo, Belsomra, Steglatro |
| Glaxosmithkline, LLC. | $68.61 | 2021-2024 | Trelegy Ellipta |
| Gilead Sciences, INC. | $37.89 | 2019 | |
| Abbott Laboratories | $36.27 | 2021 | |
| Ucb, INC. | $34.96 | 2025 | Rystiggo |
| Verona Pharma, INC. | $31.69 | 2025 | Ohtuvayre |
| Otsuka America Pharmaceutical, INC. | $29.63 | 2023 | Rexulti |
| Medtronic, INC. | $21.99 | 2022 | |
| Mallinckrodt Hospital Products INC. | $21.28 | 2022 | |
| Kyowa Kirin, INC. | $20.97 | 2023 | Crysvita |
| Novo Nordisk INC | $15.20 | 2023 | Ozempic, Rybelsus |
| Amgen INC. | $15.09 | 2020 | |
| Pfizer INC. | $14.92 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.55 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.29 | 2022 | |
| Esperion Therapeutics, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Norman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.